Advanced Energy Solution Holding Co., Ltd. (TPE:6781)
1,200.00
-45.00 (-3.61%)
Aug 1, 2025, 2:38 PM CST
Blueprint Medicines Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2020 |
---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2020 |
11,168 | 10,037 | 10,032 | 15,052 | 11,550 | 6,307 | Upgrade | |
Revenue Growth (YoY) | 18.58% | 0.05% | -33.36% | 30.33% | 83.14% | 29.78% | Upgrade |
Cost of Revenue | 6,754 | 6,081 | 6,265 | 9,486 | 7,374 | 4,290 | Upgrade |
Gross Profit | 4,414 | 3,956 | 3,767 | 5,566 | 4,175 | 2,017 | Upgrade |
Selling, General & Admin | 559.84 | 558.3 | 498.43 | 533.08 | 440.96 | 318.46 | Upgrade |
Research & Development | 1,040 | 1,018 | 1,077 | 1,084 | 708.21 | 470.67 | Upgrade |
Operating Expenses | 1,600 | 1,577 | 1,576 | 1,617 | 1,148 | 790.34 | Upgrade |
Operating Income | 2,814 | 2,379 | 2,191 | 3,949 | 3,027 | 1,226 | Upgrade |
Interest Expense | -36.9 | -105.29 | -87.7 | -49.4 | -0.11 | -1.19 | Upgrade |
Interest & Investment Income | 350.96 | 351.34 | 305.26 | 115.35 | 18.72 | 17.26 | Upgrade |
Currency Exchange Gain (Loss) | 34.87 | 72.99 | 34.96 | 38.57 | 17.97 | -76.15 | Upgrade |
Other Non Operating Income (Expenses) | 38.54 | 37.27 | 42.96 | 20.74 | 23.81 | 31.62 | Upgrade |
EBT Excluding Unusual Items | 3,202 | 2,736 | 2,486 | 4,074 | 3,087 | 1,198 | Upgrade |
Gain (Loss) on Sale of Assets | 17.74 | 18.09 | -0.83 | -1.03 | -0.43 | 3.31 | Upgrade |
Pretax Income | 3,220 | 2,754 | 2,485 | 4,073 | 3,087 | 1,201 | Upgrade |
Income Tax Expense | 684.44 | 585.05 | 517.03 | 855.4 | 650.51 | 294.36 | Upgrade |
Earnings From Continuing Operations | 2,535 | 2,169 | 1,968 | 3,218 | 2,436 | 906.91 | Upgrade |
Minority Interest in Earnings | -0.09 | -0.05 | -0.06 | -0.1 | -1.49 | -3.58 | Upgrade |
Net Income | 2,535 | 2,169 | 1,968 | 3,218 | 2,435 | 903.33 | Upgrade |
Net Income to Common | 2,535 | 2,169 | 1,968 | 3,218 | 2,435 | 903.33 | Upgrade |
Net Income Growth | 39.59% | 10.18% | -38.83% | 32.15% | 169.55% | 50.56% | Upgrade |
Shares Outstanding (Basic) | 85 | 85 | 85 | 85 | 81 | 64 | Upgrade |
Shares Outstanding (Diluted) | 86 | 86 | 86 | 86 | 81 | 65 | Upgrade |
Shares Change (YoY) | -0.03% | -0.05% | -0.10% | 5.85% | 25.18% | 1.38% | Upgrade |
EPS (Basic) | 29.68 | 25.39 | 23.04 | 37.67 | 30.18 | 14.17 | Upgrade |
EPS (Diluted) | 29.64 | 25.36 | 23.01 | 37.58 | 30.10 | 13.98 | Upgrade |
EPS Growth | 39.55% | 10.21% | -38.77% | 24.85% | 115.31% | 48.57% | Upgrade |
Free Cash Flow | 2,088 | 1,999 | -765.6 | 1,687 | 863.43 | 211.94 | Upgrade |
Free Cash Flow Per Share | 24.42 | 23.38 | -8.95 | 19.70 | 10.67 | 3.28 | Upgrade |
Dividend Per Share | 12.500 | 12.500 | 11.600 | 19.000 | 15.000 | 5.300 | Upgrade |
Dividend Growth | 7.76% | 7.76% | -38.95% | 26.67% | 183.02% | - | Upgrade |
Gross Margin | 39.52% | 39.41% | 37.55% | 36.98% | 36.15% | 31.98% | Upgrade |
Operating Margin | 25.20% | 23.71% | 21.84% | 26.24% | 26.21% | 19.45% | Upgrade |
Profit Margin | 22.70% | 21.61% | 19.62% | 21.38% | 21.08% | 14.32% | Upgrade |
Free Cash Flow Margin | 18.70% | 19.92% | -7.63% | 11.21% | 7.48% | 3.36% | Upgrade |
EBITDA | 3,096 | 2,663 | 2,453 | 4,153 | 3,156 | 1,313 | Upgrade |
EBITDA Margin | 27.72% | 26.53% | 24.45% | 27.59% | 27.33% | 20.82% | Upgrade |
D&A For EBITDA | 281.19 | 283.63 | 262.53 | 203.58 | 129.11 | 86.75 | Upgrade |
EBIT | 2,814 | 2,379 | 2,191 | 3,949 | 3,027 | 1,226 | Upgrade |
EBIT Margin | 25.20% | 23.71% | 21.84% | 26.24% | 26.21% | 19.45% | Upgrade |
Effective Tax Rate | 21.26% | 21.25% | 20.80% | 21.00% | 21.07% | 24.50% | Upgrade |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.